In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s15010-020-01470-z | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!